Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) remains treatment refractory. Immunotherapy has achieved success in the treatment of multiple malignancies. However, the efficacy of immunotherapy in PDAC is limited by a lack of promising biomarkers. In this research, we aimed to identify robust i...

全面介紹

Na minha lista:
書目詳細資料
發表在:Front Immunol
Main Authors: Li, Ruiyu, He, Yangzhige, Zhang, Hui, Wang, Jing, Liu, Xiaoding, Liu, Hangqi, Wu, Huanwen, Liang, Zhiyong
格式: Artigo
語言:Inglês
出版: Frontiers Media S.A. 2021
主題:
Immunology
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC8320597/
https://ncbi.nlm.nih.gov/pubmed/34335594
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.690056
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍